Literature DB >> 20012200

An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.

Paula M Frew1, Matthew Archibald, Dazon Dixon Diallo, Su-I Hou, Takeia Horton, Kayshin Chan, Mark J Mulligan, Carlos del Rio.   

Abstract

In the United States, the number and proportion of HIV/AIDS cases among black/African Americans continue to highlight the need for new biomedical prevention interventions, including an HIV vaccine, microbicide, or new antiretroviral (ARV) prevention strategies such as pre-exposure prophylaxis (PrEP) to complement existing condom usage, harm reduction methods, and behavioral change strategies to stem the HIV epidemic. Although black/African Americans are disproportionately impacted by HIV/AIDS, their participation in HIV clinical research continues to have unique challenges. We theorize that interaction among multilevel factors creates ideal alignment for minority participation in HIV clinical studies. Thus, we initially set out to test an extended model of reasoned action with 362 participants to understand the interplay of sociopsychological and network-level considerations influencing minority participation in HIV prevention research efforts. In this study, we linked the intrapersonal dimensions of attitudes, beliefs, and normative concerns to community-level components, appraisal of involvement with the clinical research organization, an entity which operates within a networked structure of community partner agencies, and identification with coalition advocacy aims. Various participatory outcomes were explored including involvement in future HIV vaccine community functions, participation in community promotion of HIV vaccine research, and community mobilization. Three-stage least squares estimates indicated similar findings across three models. Significant effects demonstrate the importance of positive attitudes toward HIV vaccine research, favorable health research beliefs, perceived social support for participation, HIV/AIDS issue engagement, and perceived relevance of the clinical research site's mission and values. Identification of these nuanced pathway effects provides implications for tailored community program development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20012200      PMCID: PMC2858782          DOI: 10.1007/s11121-009-0162-9

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  53 in total

Review 1.  Microbicides in HIV prevention.

Authors:  S McCormack; R Hayes; C J Lacey; A M Johnson
Journal:  BMJ       Date:  2001-02-17

2.  A venue-based method for sampling hard-to-reach populations.

Authors:  F B Muhib; L S Lin; A Stueve; R L Miller; W L Ford; W D Johnson; P J Smith
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

3.  The influence of religion on organ donation and transplantation among the Black Caribbean and Black African population--a pilot study in the United Kingdom.

Authors:  Cynthia Davis; Gurch Randhawa
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

4.  Towards a science of community engagement.

Authors:  Peter A Newman
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

5.  HIV vaccine research: the way forward.

Authors:  Anthony S Fauci; Margaret I Johnston; Carl W Dieffenbach; Dennis R Burton; Scott M Hammer; James A Hoxie; Malcolm Martin; Julie Overbaugh; David I Watkins; Adel Mahmoud; Warner C Greene
Journal:  Science       Date:  2008-07-25       Impact factor: 47.728

6.  Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States.

Authors:  Mary A Allen; Thomas S Liang; Thomas La Salvia; Brian Tjugum; Robert J Gulakowski; Matthew Murguía
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

7.  Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.

Authors:  R P Strauss; S Sengupta; S Kegeles; E McLellan; D Metzger; S Eyre; F Khanani; C B Emrick; K M MacQueen
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

8.  Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  B A Koblin; S Holte; B Lenderking; P Heagerty
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-15       Impact factor: 3.731

9.  Subpopulation estimates from the HIV incidence surveillance system--United States, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-09-12       Impact factor: 17.586

10.  High-risk sexual behavior and condom use among gay and bisexual African-American men.

Authors:  J L Peterson; T J Coates; J A Catania; L Middleton; B Hilliard; N Hearst
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

View more
  12 in total

1.  Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.

Authors:  Paula M Frew; Julia E Painter; Brooke Hixson; Carolyn Kulb; Kathryn Moore; Carlos del Rio; Alejandra Esteves-Jaramillo; Saad B Omer
Journal:  Vaccine       Date:  2012-04-23       Impact factor: 3.641

2.  Prototypes reflect normative perceptions: implications for the development of reasoned action theory.

Authors:  Michael Hennessy; Amy Bleakley; Morgan Ellithorpe
Journal:  Psychol Health Med       Date:  2017-06-14       Impact factor: 2.423

3.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

4.  Factors associated with seasonal influenza immunization among church-going older African Americans.

Authors:  Sahithi Boggavarapu; Kevin M Sullivan; Jay T Schamel; Paula M Frew
Journal:  Vaccine       Date:  2014-11-05       Impact factor: 3.641

5.  Neighborhood Influences on Seasonal Influenza Vaccination among Older African Americans in Atlanta, Georgia.

Authors:  N Niyibizi; J Schamel; P M Frew
Journal:  J Immunol Tech Infect Dis       Date:  2016-03-23

6.  Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation.

Authors:  Paula M Frew; Mark J Mulligan; Su-I Hou; Kayshin Chan; Carlos del Rio
Journal:  Open Access J Clin Trials       Date:  2010-09-01

7.  Delivering a "dose of hope": a faith-based program to increase older african americans' participation in clinical trials.

Authors:  Paula M Frew; Saad B Omer; Kimberly Parker; Marcus Bolton; Jay Schamel; Eve Shapiro; Lauren Owens; Diane Saint-Victor; Sahithi Boggavarapu; Nikia Braxton; Matthew Archibald; Ameeta S Kalokhe; Takeia Horton; Christin M Root; Vincent L Fenimore; Aaron M Anderson
Journal:  JMIR Res Protoc       Date:  2015-06-02

8.  The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania.

Authors:  Theodora Mbunda; Edith A M Tarimo; Guerino Chalamilla; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

9.  Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.

Authors:  Dan Allman; Melissa Hope Ditmore; Karyn Kaplan
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

10.  Results of a Community Randomized Study of a Faith-Based Education Program to Improve Clinical Trial Participation among African Americans.

Authors:  Paula M Frew; Jay T Schamel; Kelli A O'Connell; Laura A Randall; Sahithi Boggavarapu
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.